The latest immunotherapy news and developments
A new form of immunotherapy using innovative nanoparticles can delay resistance to hormone therapy and…
A protein called Meteorin-like (METRNL) in the tumour microenvironment saps energy from T cells, thereby…
Progenitor exhausted CD8+ T (Tpex) cells have emerged as a pivotal component in tumour immunotherapy due…
Oncolytic virus (OV)-based immunotherapy has emerged as a promising strategy for cancer treatment, offering a…
Patients with liver cancer who received immune checkpoint inhibitors (ICIs) before surgery – including those who would…
Enhancer of zeste homolog 2 (EZH2) is a catalytic subunit of the Polycomb-repressive complex 2…
Two studies published in the latest issue of the journal Cell by University of Pittsburgh researchers…
In the past two decades, immune checkpoint inhibitors (ICIs) have revolutionised cancer treatment, showing promising…
CAR-T cells are highly effective in treating selected blood cancers. However, challenges remain with this…
The effectiveness of CAR T cell therapy against a variety of cancers, including solid tumours,…